Abstract
The National Registry of Drug-Induced Ocular Side effects has received 79 cases reports of suspected hematopoietic toxicity caused by carbonic anhydrase inhibitors. Twenty-six of these suspected cases (32%) resulted in death secondary to aplastic anemia, thrombocytopenia, or granulocytosis. In 54 of these 79, adverse reactions (68% occurred during the first six months of therapy).
| Original language | English (US) |
|---|---|
| Pages (from-to) | 79-81 |
| Number of pages | 3 |
| Journal | American journal of ophthalmology |
| Volume | 100 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 1985 |
ASJC Scopus subject areas
- Ophthalmology
Fingerprint Dive into the research topics of 'Hematologic reactions to carbonic anhydrase inhibitors'. Together they form a unique fingerprint.
Cite this
Fraunfelder, F. T., Meyer, S. M., Bagby, G. C., & Dreis, M. W. (1985). Hematologic reactions to carbonic anhydrase inhibitors. American journal of ophthalmology, 100(1), 79-81. https://doi.org/10.1016/S0002-9394(14)74987-6